ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer

NCT01675128 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Colorectal Neoplasms
Colorectal Carcinoma
Colorectal Tumors

Interventions

DRUG: ISIS 183750
DRUG: Irinotecan

Sponsor

National Cancer Institute (NCI)